EFFICACY OF PROPRANOLOL IN TRAUMATIC BRAIN INJURY PATIENTS ADMITTED TO THE ICU: A PROSPECTIVE, RANDOMIZED, TRIPLE-BLIND STUDY (ProP TBI in ICU)

2025-524194-17-00 · tracked via the Priya Life Science EU tracker

Sponsor

University Hospital Son Espases

Sponsor type

Hospital/Clinic/Other health care facility

Therapeutic area

Nervous System Diseases

Decision date

05/02/2026

Enrollment target

600

Sites

Spain

Condition studied

Head injury

Investigational medicinal product(s)

METHYLCELLULOSEPropranolol 10 mg Tablets

Eligibility

Age group

18-64 years, 65+ years

Sex

Female, Male

Primary endpoint

Hospital mortality

Endpoint detail

Glasgow outcome scale extended

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524194-17-00 on CTIS ↗ ← All trials in the EU